共 50 条
Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the United Kingdom
被引:0
作者:
Xie, J.
[1
]
Yong, A. S. M.
[2
]
Waweru, C.
[1
]
Sorof, T. -A.
[3
]
Goyal, R. K.
[4
]
Davis, K. L.
[4
]
Hillmen, P.
[5
]
机构:
[1] AstraZeneca LP, Gaithersburg, MD USA
[2] AstraZeneca, Luton, Beds, England
[3] Acerta Pharma, San Francisco, CA USA
[4] RTI Hlth Solut, Res Triangle Pk, NC USA
[5] St James Univ Hosp, Leeds, W Yorkshire, England
关键词:
D O I:
暂无
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
BSH2020-EP
引用
收藏
页码:221 / 221
页数:1
相关论文